Dr. Wesley Kufel presents lessons learned from a complicated patient case about the pharmacokinetics and pharmacodynamics of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant Acinetobacter baumannii-calcoaceticus (CRAB) complex. Read the full text open access manuscript at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70027" target="_blank" rel="ugc noopener noreferrer">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70027</a>

Dr. Wesley Kufel presents lessons learned from a complicated patient case about the pharmacokinetics and pharmacodynamics of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant Acinetobacter baumannii-calcoaceticus (CRAB) complex. Read the full text open access manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70027

Dr. Wesley Kufel presents lessons learned from a complicated patient case about the pharmacokinetics and pharmacodynamics of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant&nbsp;Acinetobacter baumannii-calcoaceticus&nbsp;(CRAB) complex. Read the full text open access manuscript at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70027" rel="noopener noreferrer">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70027</a>

PK/PD evaluation of sulbactam-durlobactam in a critically ill patient - Ep 165

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice.
ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Medicine

Health & Fitness

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice. ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Share PK/PD evaluation of sulbactam-durlobactam in a critically ill patient - Ep 165

Sign up to save your podcasts

PK/PD evaluation of sulbactam-durlobactam in a critically ill patient - Ep 165

PK/PD evaluation of sulbactam-durlobactam in a critically ill patient - Ep 165

More shows like ACCP JOURNALS

NEJM This Week

JAMA Clinical Reviews

JACC This Week

Diabetes Core Update

The Curbsiders Internal Medicine Podcast

Emergency Medical Minute

Core IM | Internal Medicine Podcast

Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Annals On Call Podcast

Breakpoints

Run the List

Critical Care Scenarios

Febrile

Good Inside with Dr. Becky

Critical Care Time